U.S. Private-Equity Firm I Squared Leads Race for KKR's Singapore Logistics Asset
I Squared is conducting due diligence for KKR's logistics company, Goodpack, the people said. Other bidders for the asset include global investment firms such as Brookfield Asset Management and Apollo Global Management, they said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
If EPS Growth Is Important To You, Objective (ASX:OCL) Presents An Opportunity
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, then you may well be interested in Objective (ASX:OCL). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That means EPS growth is considered a real positive by most successful long-term investors. It certainly is nice to see that Objective has managed to grow EPS by 21% per year over three years. So it's not surprising to see the company trades on a very high multiple of (past) earnings. Top-line growth is a great indicator that growth is sustainable, and combined with a high earnings before interest and taxation (EBIT) margin, it's a great way for a company to maintain a competitive advantage in the market. The music to the ears of Objective shareholders is that EBIT margins have grown from 28% to 32% in the last 12 months and revenues are on an upwards trend as well. That's great to see, on both counts. The chart below shows how the company's bottom and top lines have progressed over time. Click on the chart to see the exact numbers. See our latest analysis for Objective In investing, as in life, the future matters more than the past. So why not check out this free interactive visualization of Objective's forecast profits? Prior to investment, it's always a good idea to check that the management team is paid reasonably. Pay levels around or below the median, can be a sign that shareholder interests are well considered. The median total compensation for CEOs of companies similar in size to Objective, with market caps between AU$611m and AU$2.4b, is around AU$1.7m. The Objective CEO received total compensation of just AU$215k in the year to June 2024. First impressions seem to indicate a compensation policy that is favourable to shareholders. While the level of CEO compensation shouldn't be the biggest factor in how the company is viewed, modest remuneration is a positive, because it suggests that the board keeps shareholder interests in mind. It can also be a sign of a culture of integrity, in a broader sense. If you believe that share price follows earnings per share you should definitely be delving further into Objective's strong EPS growth. Strong EPS growth is a great look for the company and reasonable CEO compensation sweetens the deal for investors ass it alludes to management being conscious of frivolous spending. We think that based on its merits alone, this stock is worth watching into the future. Of course, profit growth is one thing but it's even better if Objective is receiving high returns on equity, since that should imply it can keep growing without much need for capital. Click on this link to see how it is faring against the average in its industry. While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in AU with promising growth potential and insider confidence. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
43 minutes ago
- Yahoo
Dexter Dennis with the 2 Pt
Opinion: Pat Verbeek's Inability to Leverage, Cause for Concern The NHL Draft is in the books, and we are four days removed from the opening of NHL free agency. Every significant unrestricted free agent is off the board, leaving the trade market as the only option for teams looking to meaningfully improve before the start of the 2025-26 season. 3:42 Now Playing Paused Ad Playing
Yahoo
an hour ago
- Yahoo
Secret Super Stocks: If You Invested $1K in These 3 Companies 5 Years Ago, See What You'd Have Today
Most people think you need to be rich to make big money in the stock market. But what if all it took was spotting the right stock at the right time and investing just $1,000? While you might try to strike it big with well-known names like Apple, Tesla or Amazon, there are smaller companies that put up incredible returns. Discover More: For You: Take a look at three high-performing 'unknown' stocks over the past five years. If you had invested just $1,000 in each, you'd be sitting on over $230,000 right now. Let's break down the three silent winners and what made them explode. Note that these stocks were available at very low prices because they were 'penny stocks' that were only available as an Over-The-Counter (OTC) stock. You must use a broker that supports OTC trades to invest in stocks like these. Kolobri Energy Inc. (KGEI) is a small oil and energy company located in Oklahoma. Previously known as BNK Petroleum Inc., the company owns and operates Caney Shale oil wells — extracting crude oil, natural gas, and natural gas liquids from the wells. The stock took off in early 2022 and has since skyrocketed from less than $0.10 per share, to over $7 per share. If you'd dropped just $1,000 into Kolibri five years ago, you'd be sitting on over $100 grand today. KGEI has returned 10,429% in the last 5 years alone. This would have turned your $1,000 investment into $105,290! Kolibri stock has already had a massive upside move, but there is still room for continued growth. The stock still has a relatively low price-to-earnings ratio (around 12), and continues to grow revenue year-over-year. Never heard of Viewbix? You're not alone. Viewbix Inc. is a smaller Israeli-based digital advertising platform that focuses on providing solutions for clients through search and digital content. This Ad-tech company stock was only available as an OTC stock until recently, when it was listed on the Nasdaq under ticker symbol VBIX. If you were buying OTC stocks back in 2020, you'd have been able to pick up this stock for around $0.05 per share. The company stock was relatively flat until late 2022, when it shot up from around $0.08 per share to over $3 per share within a year. It now sits around $4.50 per share, which is a 6,917% increase since 2020! If you invested $1,000 in Viewbix Inc. 5 years ago, you'd have around $70,170 today. And now that the company has listed on the Nasdaq exchange, there's more potential growth. Just keep an eye on revenue, which has been declining in recent years. Plus the company has yet to turn a profit, so proceed with caution. BioHarvest Sciences Inc. (BHST) is a biotech company doing futuristic things with plant cells — think dietary supplements and functional foods, all made in a lab. It also dabbles in cosmetics and health pharmaceuticals as well. If you were an early investor in BHST 5 years ago and dedicated to purchasing shares over the counter, you'd have bought them at around $0.12 per share. But with recent company growth and uplisting to the Nasdaq exchange in 2024, BHST stock is now trading for over $7 per share. This means your $1,000 would have turned into $57,190! This is another company still in growth mode, and hasn't seen a profitable year yet. But with revenues doubling year-over-year, there may still be even more upside potential. Just recognize this is still a very speculative investment. Seeing these eye-popping returns, you might be tempted to drum up $1,000 to drop in a small, unknown stock. But most micro-cap stocks don't see this type of growth — as many simply go out of business — leaving investors with $0. Plus, most of these explosive stocks have seen massive gains for investors that bought before being listed on a major exchange. This means purchasing Over-The-Counter (OTC), which requires working with a broker that supports OTC listings. It's higher risk, higher (potential) rewards. But if you're willing to do the leg-work of market research, technical analysis, and dig into the details of dozens of stocks, you might find a diamond in the rough. Just don't invest any money you aren't willing to lose. Editor's note: All stock prices were sourced from Stock Analysis. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 6 Hybrid Vehicles To Stay Away From in Retirement How Much Money Is Needed To Be Considered Middle Class in Your State? This article originally appeared on Secret Super Stocks: If You Invested $1K in These 3 Companies 5 Years Ago, See What You'd Have Today Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
